Raymond Osarogiagbon, MD, discusses innovative strategies for improving lung cancer screening, including artificial intelligence (AI) tools and simplified eligibility criteria.

The escalating burden of lung, breast, and gastric cancers across Asia presents a pressing public health challenge, compounded by the region’s vast ...

A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...

AstraZeneca, in partnership with health-tech company Qure.ai, recently announced the successful completion of 5 million artificial intelligence (AI)-enabled chest X-rays (CXRs) across more than 20 ...

BUFFALO, N.Y. — University at Buffalo medicinal chemist David Heppner has received the 2025 Philip S. Portoghese Lectureship ...

A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...

A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from ...

Ipilimumab, a cancer immunotherapy, reduced scar formation and promoted tissue regeneration in a mouse model of idiopathic ...

Scientists at Ankara University have developed an AI tool that detects early-stage lung cancer with over 90% accuracy by ...

Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering ...

In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the ...